The combination of the active ingredients of dermamelan® has shown a high efficacy in vitro, regulating both intracellular (inhibition of MITF, tyrosinase and other melanogenesis enzymes and transfer of melanin to the keratinocyte) and intercellular processes (acting in different signalling pathways in which several cell types are involved). The result of the formula is a total reduction of melanin synthesis of 89%.
WETENSCHAPPELIJKE STUDIE AANVRAGEN